Notably, PART patients show a higher degree of tau hyperphosphorylation in the entorhinal cortex (EC) than AD, yet the molecular mechanisms driving Aβ‐independent tau hyperphosphorylation in PART remain poorly understood. The gene discussed is MAPT; the disease is Alzheimer disease.